development and validation of immunoenzyme test-system for determination of 25-hydroxyvitamin d in blood serum

Clicks: 212
ID: 190748
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #9 of 15 articles by views in third world quarterly

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The present study was aimed at designing of immunoenzyme test-system for competitive determination of 25OHD in blood serum using polyclonal antibodies against 25OHD and biotin-streptavidin visualization technique. The validation parameters of test-system were determined. For development of test-system we used the preparation of specific antibodies against 25OHD with the titer 1:3000. The optimal concentration of competing agent (25OHD3-LC-biotin) was found to be equal to 5 ng/ml. The standard calibration curve was built by using a set of seven calibrators. For the validation of test-system the following parameters were established: limit of detection, quantitative limit, cross-reactivity, intra- and inter-system coefficients of variation (Intra.CV, Inter.CV) and “matrix effect”. Constructed immunoenzyme test-system can be used successfully for 25OHD determination in blood serum samples.
Reference Key
2016biotechnologiadevelopment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;A. O. ;I. O. ; M. M.
Journal third world quarterly
Year 2016
DOI
10.15407/biotech9.02.028
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.